.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Chinese Patent Office
Fish and Richardson
Covington
Federal Trade Commission
Fuji
Dow
McKinsey
Healthtrust
Boehringer Ingelheim

Generated: September 21, 2017

DrugPatentWatch Database Preview

ACETAMINOPHEN AND HYDROCODONE BITARTRATE Drug Profile

« Back to Dashboard

Which patents cover Acetaminophen And Hydrocodone Bitartrate, and what generic Acetaminophen And Hydrocodone Bitartrate alternatives are available?

Acetaminophen And Hydrocodone Bitartrate is a drug marketed by Cent Pharms and is included in one NDA.

The generic ingredient in ACETAMINOPHEN AND HYDROCODONE BITARTRATE is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Summary for Tradename: ACETAMINOPHEN AND HYDROCODONE BITARTRATE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list106,470
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACETAMINOPHEN AND HYDROCODONE BITARTRATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cent Pharms
ACETAMINOPHEN AND HYDROCODONE BITARTRATE
acetaminophen; hydrocodone bitartrate
CAPSULE;ORAL088898-001Mar 27, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Argus Health
McKesson
Deloitte
Novartis
Cerilliant
Queensland Health
Fish and Richardson
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot